Form 4: Veracyte CCO's Tax Withholding on RSU Vesting

Veracyte's Chief Commercial Officer, John Leite, had 2,902 shares withheld to cover tax obligations related to restricted stock unit vesting on September 2, 2025.

Summary

• John Leite, Chief Commercial Officer of Veracyte, Inc. (VCYT), reported a transaction on September 2, 2025.
• The transaction involved the disposition of 2,902 shares of Veracyte Common Stock at a price of $30.11 per share.
• This disposition was solely for tax withholding purposes in connection with the vesting of restricted stock units and does not represent a discretionary sale by Mr. Leite.
• Following this transaction, Mr. Leite beneficially owns 91,638 shares of Veracyte Common Stock.

Sentiment

Score: 5

Explanation: The filing reports a routine tax withholding transaction related to RSU vesting for an executive, which is a neutral event for the company's operational or strategic outlook.

Positives

• The transaction indicates the vesting of restricted stock units (RSUs) for the Chief Commercial Officer, suggesting continued long-term incentive alignment and retention of key management.

Negatives

• No direct negative implications as the reported transaction is a routine tax withholding event related to RSU vesting, not a discretionary sale.

Risks

• NA

Future Outlook

NA

Management Comments

• NA

Industry Context

NA

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• NA

Related Party Transactions

• NA

Stakeholder Impact

• Shareholders: Provides transparency on executive compensation and share ownership.
• Employees: Reflects standard executive compensation practices.

Next Steps

• NA

Key Dates

Keywords

Veracyte, VCYT, John Leite, Chief Commercial Officer, Form 4, insider transaction, RSU vesting, tax withholding, common stock